Provided by Tiger Trade Technology Pte. Ltd.

Natera

383.68
-11.8850-3.00%
Volume:327.87K
Turnover:126.70M
Market Cap:54.95B
PE:-279.46
High:392.96
Open:388.00
Low:381.95
Close:395.56
52wk High:437.41
52wk Low:167.99
Shares:143.22M
Float Shares:139.00M
Volume Ratio:1.31
T/O Rate:0.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3729
EPS(LYR):-1.5269
ROE:-12.54%
ROA:-8.08%
PB:30.17
PE(LYR):-251.28

Loading ...

Natera (NTRA) On Prospera Coverage Expansion And Revenue Strength Looks Fully Valued

Simply Wall St.
·
Jul 18

Natera Co-founder, Director Sheena Jonathan Disposes of 1,500 Common Shares Worth $410,322.91

Reuters
·
Jul 18

Natera Says Finalized Moldx Coverage Expands Prospera Surveillance Testing for Kidney, Heart, Lung Transplants

Reuters
·
Jul 17

Natera Co-founder, Director Sheena Jonathan Sells 3,150 Shares Worth $835,835.18

Reuters
·
Jul 16

Goldman Sachs Reaffirms Their Hold Rating on Natera (NTRA)

TIPRANKS
·
Jul 16

Natera Inc : TD Cowen Raises Target Price to $325 from $280

THOMSON REUTERS
·
Jul 15

Natera is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 14

Natera price target raised to $330 from $285 at Canaccord

TIPRANKS
·
Jul 14

Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts

Simply Wall St.
·
Jul 13

Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification?

Simply Wall St.
·
Jul 11

July 2026's Top Stock Picks Estimated To Be Trading Below Fair Value

Simply Wall St.
·
Jul 11

U.S. Stocks on the Move-natera, Nlight, Micron

Reuters
·
Jul 10

Natera is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 10

Analysts Are Bullish on These Healthcare Stocks: Natera (NTRA), Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jul 10

Natera Shares Gain 2.8% After EU Certification for Cancer Test

THOMSON REUTERS
·
Jul 09

How New Signatera Colorectal Data and Trial Deals Could Shape Natera’s (NTRA) Long-Term Narrative

Simply Wall St.
·
Jul 09

Natera price target raised to $310 from $250 at Morgan Stanley

TIPRANKS
·
Jul 09

Natera Announces Ivdr Certification for Signatera™ Across Multiple Cancers

THOMSON REUTERS
·
Jul 09

Natera’s Signatera MRD Test Wins EU IVDR Certification for Multiple Cancers

Reuters
·
Jul 09

Natera Executive Chairman Matthew Rabinowitz Reports Disposal of 1,000 Common Shares Worth $280,000

Reuters
·
Jul 09